Beneficial Effect of Maintaining Hepatic Reserve during Chemotherapy on the Outcomes of Patients with Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Beneficial Effect of Maintaining Hepatic Reserve during Chemotherapy on the Outcomes of Patients with Hepatocellular Carcinoma

Published:2017 Issue:3 Volume:6 Page:236-249
ISSN:2235-1795
Container-title:Liver Cancer
language:en
Short-container-title:Liver Cancer

Author:

Terashima Takeshi,Yamashita Tatsuya,Arai Kuniaki,Kawaguchi Kazunori,Kitamura Kazuya,Yamashita Taro,Sakai Yoshio,Mizukoshi Eishiro,Honda Masao,Kaneko Shuichi

Publisher

S. Karger AG

Subject

Oncology,Hepatology

Reference20 articles.

1. Siegel RL, Miller KD, Jemal A: Cancer statistics, 2016. CA Cancer J Clin 2016;66:7-30.

2. Yamashita T, Kitao A, Matsui O, Hayashi T, Nio K, Kondo M, et al: Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma. Hepatology 2014;60:1674-1685.

3. Song MJ, Chun HJ, Song do S, Kim HY, Yoo SH, Park CH, et al: Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma. J Hepatol 2012;57:1244-1250.

4. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:378-390.

5. Yamashita T, Arai K, Sunagozaka H, Ueda T, Terashima T, Yamashita T, et al: Randomized, phase II study comparing interferon combined with hepatic arterial infusion of fluorouracil plus cisplatin and fluorouracil alone in patients with advanced hepatocellular carcinoma. Oncology 2011;81:281-290.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel liver-function-indicators-based prognosis signature for patients with hepatocellular carcinoma treated with anti-programmed cell death-1 therapy;Cancer Immunology, Immunotherapy;2024-06-04

2. Transarterial Chemoembolization (TACE) Combined with Lenvatinib versus TACE Alone in Intermediate-Stage Hepatocellular Carcinoma Patients Beyond Up-To-Seven Criteria: A Retrospective, Propensity Score-Matched Analysis;Academic Radiology;2024-05

3. Transarterial Chemoembolization (TACE) Combined with Lenvatinib versus TACE Alone in Intermediate-Stage Hepatocellular Carcinoma Patients Beyond Up-To-Seven Criteria: A Retrospective, Propensity Score-Matched Analysis;2024-02-07

4. Conversion therapy for initially unresectable hepatocellular carcinoma: Current status and prospects;BioScience Trends;2023-12-31

5. Nutritional risk index predicts the prognosis of gastric cancer patients with pyloric stenosis who received preoperative parenteral nutrition;Oncology Letters;2023-07-31